Literature DB >> 15784588

Genetic diversity and carriage dynamics of Neisseria lactamica in infants.

Julia S Bennett1, David T Griffiths, Noel D McCarthy, Karen L Sleeman, Keith A Jolley, Derrick W Crook, Martin C J Maiden.   

Abstract

Neisseria lactamica, a harmless human commensal found predominantly in the upper respiratory tracts of infants, is closely related to Neisseria meningitidis, a pathogen of global significance. Colonization with N. lactamica may be responsible for the increase in immunity to meningococcal disease that occurs during childhood, when rates of meningococcal carriage are low. This observation has led to the suggestion that N. lactamica whole cells or components are potential constituents of novel meningococcal vaccines. However, the dynamics of carriage and population diversity of N. lactamica in children are poorly understood, presenting difficulties for the choice of representative isolates for use in vaccine development. This problem was addressed by the multilocus sequence typing of N. lactamica isolates from two longitudinal studies of bacterial carriage in infants. The studies comprised 100 and 216 subjects, with N. lactamica carriage monitored from age 4 weeks until age 96 weeks and from age 2 weeks until age 24 weeks, respectively. The maximum observed carriage rate was 44% at 56 weeks of age, with isolates obtained on multiple visits for the majority (54 of 75, 72%) of carriers. The N. lactamica isolates were genetically diverse, with 69 distinct genotypes recovered from the 75 infants. Carriage was generally long-lived, with an average rate of loss of under 1% per week during the 28 weeks following acquisition. Only 11 of the 75 infants carried more than one genotypically unique isolate during the course of the study. Some participants shared identical isolates with siblings, but none shared identical isolates with their parents. These findings have implications for the design of vaccines based on this organism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784588      PMCID: PMC1087434          DOI: 10.1128/IAI.73.4.2424-2432.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  MEGA2: molecular evolutionary genetics analysis software.

Authors:  S Kumar; K Tamura; I B Jakobsen; M Nei
Journal:  Bioinformatics       Date:  2001-12       Impact factor: 6.937

2.  Report of the ad hoc committee for the re-evaluation of the species definition in bacteriology.

Authors:  Erko Stackebrandt; Wilhelm Frederiksen; George M Garrity; Patrick A D Grimont; Peter Kämpfer; Martin C J Maiden; Xavier Nesme; Ramon Rosselló-Mora; Jean Swings; Hans G Trüper; Luc Vauterin; Alan C Ward; William B Whitman
Journal:  Int J Syst Evol Microbiol       Date:  2002-05       Impact factor: 2.747

Review 3.  Multi-locus sequence typing: a tool for global epidemiology.

Authors:  Rachel Urwin; Martin C J Maiden
Journal:  Trends Microbiol       Date:  2003-10       Impact factor: 17.079

4.  Genetic diversity of Neisseria lactamica strains from epidemiologically defined carriers.

Authors:  D Alber; M Oberkötter; S Suerbaum; H Claus; M Frosch; U Vogel
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

5.  Structural analysis of the variation in the major outer membrane proteins of Neisseria meningitidis and related species.

Authors:  J Suker; I M Feavers; M C Maiden
Journal:  Biochem Soc Trans       Date:  1993-05       Impact factor: 5.407

6.  Carriage of Neisseria meningitidis and Neisseria lactamica in northern Greece.

Authors:  Jenny Kremastinou; Georgina Tzanakaki; Stamatina Levidiotou; Fani Markou; Eleftheria Themeli; Aliki Voyiatzi; Eleni Psoma; Maria Theodoridou; C Caroline Blackwell
Journal:  FEMS Immunol Med Microbiol       Date:  2003-10-24

7.  eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data.

Authors:  Edward J Feil; Bao C Li; David M Aanensen; William P Hanage; Brian G Spratt
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

8.  Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United kingdom.

Authors:  Ray Borrow; David Goldblatt; Adam Finn; Joanna Southern; Lindsey Ashton; Nick Andrews; Gouri Lal; Christine Riley; Rukhsana Rahim; Keith Cartwright; Geraldine Allan; Elizabeth Miller
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Neisseria lactamica protects against experimental meningococcal infection.

Authors:  Kerry J Oliver; Karen M Reddin; Philippa Bracegirdle; Michael J Hudson; Ray Borrow; Ian M Feavers; Andrew Robinson; Keith Cartwright; Andrew R Gorringe
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

10.  mlstdbNet - distributed multi-locus sequence typing (MLST) databases.

Authors:  Keith A Jolley; Man-Suen Chan; Martin C J Maiden
Journal:  BMC Bioinformatics       Date:  2004-07-01       Impact factor: 3.169

View more
  30 in total

Review 1.  Evolutionary and genomic insights into meningococcal biology.

Authors:  Holly B Bratcher; Julia S Bennett; Martin C J Maiden
Journal:  Future Microbiol       Date:  2012-07       Impact factor: 3.165

2.  Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamica.

Authors:  Jay Lucidarme; Stefanie Gilchrist; Lynne S Newbold; Stephen J Gray; Edward B Kaczmarski; Lynne Richardson; Julia S Bennett; Martin C J Maiden; Jamie Findlow; Ray Borrow
Journal:  Clin Vaccine Immunol       Date:  2013-06-26

3.  Impact of Moderate Temperature Changes on Neisseria meningitidis Adhesion Phenotypes and Proteome.

Authors:  Martin Lappann; Andreas Otto; Madita Brauer; Dörte Becher; Ulrich Vogel; Kay Johswich
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

4.  Genetic, structural, and antigenic analyses of glycan diversity in the O-linked protein glycosylation systems of human Neisseria species.

Authors:  Bente Børud; Finn Erik Aas; Ashild Vik; Hanne C Winther-Larsen; Wolfgang Egge-Jacobsen; Michael Koomey
Journal:  J Bacteriol       Date:  2010-04-02       Impact factor: 3.490

5.  Carriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterization.

Authors:  Paul A Kristiansen; Fabien Diomandé; Rasmata Ouédraogo; Idrissa Sanou; Lassana Sangaré; Abdoul-Salam Ouédraogo; Absatou Ky Ba; Denis Kandolo; Jennifer Dolan Thomas; Thomas A Clark; Marie-Pierre Préziosi; F Marc Laforce; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

6.  Neisseria infection of rhesus macaques as a model to study colonization, transmission, persistence, and horizontal gene transfer.

Authors:  Nathan J Weyand; Anne M Wertheimer; Theodore R Hobbs; Jennifer L Sisko; Nyiawung A Taku; Lindsay D Gregston; Susan Clary; Dustin L Higashi; Nicolas Biais; Lewis M Brown; Shannon L Planer; Alfred W Legasse; Michael K Axthelm; Scott W Wong; Magdalene So
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 7.  Clinical and laboratory evidence for Neisseria meningitidis biofilms.

Authors:  R Brock Neil; Michael A Apicella
Journal:  Future Microbiol       Date:  2009-06       Impact factor: 3.165

8.  Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.

Authors:  Caroline Trotter; Jamie Findlow; Paul Balmer; Ann Holland; Rita Barchha; Nick Hamer; Nick Andrews; Elizabeth Miller; Ray Borrow
Journal:  Clin Vaccine Immunol       Date:  2007-05-09

9.  Meningococcal Quinolone Resistance Originated from Several Commensal Neisseria Species.

Authors:  Mingliang Chen; Chi Zhang; Xi Zhang; Min Chen
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

10.  Variation in the Neisseria lactamica porin, and its relationship to meningococcal PorB.

Authors:  Julia S Bennett; Martin J Callaghan; Jeremy P Derrick; Martin C J Maiden
Journal:  Microbiology (Reading)       Date:  2008-05       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.